Endoscopic Management of Bladder Stones: Initial Experience at a Single Center in Cameroon

Purpose: This study aimed to evaluate the efficacy and safety of endoscopic lithotripsy with the lithoclast (EMS, Switzerland) and laser Holmium YAG in the management of bladder calculi. Materials and methods: This was a retrospective study carried out from January 2013 to December 2019 on 32 patients with bladder calculi. All the patients underwent either Lithoclast or Laser lithotripsy using a 22F Storz cystoscope at the Centre medico-chirugicale d’urologie in Douala, Cameroon. Data on patients’ ages, clinical symptoms, stone sizes, type of lithotripsy, surgery duration, and results of lithotripsy were collected and analyzed using Epi info 7. Results: We recruited 32 participants (24 men and 8 women) with a median age of 41.28 [22 - 68] years into this study. In 9 (28.12%) participants, macroscopic hematuria was the main presenting complaint, followed by lower urinary tract symptoms in 8 (25%) patients. A cystoscopy was performed in 17 (53.12%) patients to con-firm the diagnosis of a a safe and effective method of management of bladder stones. This technique is also associated with short surgical procedures and postoperative hospitalization periods. We believe that it is an excellent treatment modality in the management of bladder stones.


Introduction
The urinary bladder is a sac-like organ located in the pelvic cavity. The main function of this organ is to collect and store urine before its expulsion via micturition.
The bladder, like other organs in the urinary tract, can be a location for urinary stones (calculi). These calculi develop when the minerals in urine crystalize to form stones. The minerals in question include urate, calcium oxalate, calcium phosphate, ammonium urate, cystine, and calcium-ammonium-magnesium phosphate [1]. In the literature, bladder stones are usually studied within the framework of urolithiasis and not as a separate entity. It has been reported that males are generally more predisposed to urinary stones than females [2]. Hence, as expected, the prevalence of bladder stones has also been reported to be higher in males than in females [3]. Bladder stones represent 5% of all urinary stones [4], and their clinical presentation is highly variable, ranging from being asymptomatic in some cases to having symptoms such as terminal macroscopic hematuria, suprapubic pain, recurrent infections, and irritable symptoms [5]. A CT image of a bladder stone is presented in Figure 1.
Bladder urolithiasis is mainly caused by urinary stasis, such as that due to benign prostatic hypertrophy or a neurogenic bladder. Foreign bodies that are left in the bladder and are not spontaneously expelled would eventually form layers of stone material and develop into bladder stones. In 36.7% of cases, bladder stones are associated with previous kidney stone disease [6]. The management of bladder stones depends on the clinical presentation and severity of the patient's symptoms. It ranges from conservative medical treatment to open surgery. It is important to manage large renal, ureteric, and bladder calculi in time because they could lead to more redoubtable medical conditions in the long run. Diniz et al. reported a case of renal failure due to a giant bladder stone in 2017 [7]. Medical treatment includes hyperhydration, non-steroidal anti-inflammatory drugs, and opioids in the case of refractory pain. Medical expulsive therapy (MET), which includes alpha-blockers such as doxazosin and tamsulosin, is sometimes used. Severe cases with large stones are managed surgically [8]. With recent advancements in technology, open surgery is gradually being replaced by mini-invasive procedures in the management of urolithiasis. Mini-invasive procedures have the advantages of being esthetic, being associated with shorter hos-  [9]. Currently, mini-invasive treatment options include extracorporeal shock wave lithotripsy (ESWL) and laparoscopic ureterolithotomy [10].
For bladder stones, mini-invasive lithotripsy techniques include transurethral cystolithotripsy (TUCL) and percutaneous cystolithotripsy (PCCL). According to current evidence, TUCL is the treatment of choice for bladder stones in adults and children [4]. As is the case with ureteral stones, lithotripsy of bladder stones can be performed either with the laser holmium YAG or the lithoclast (EMS, Switzerland) [11]. The long-term efficacy of mini-invasive techniques such as extracorporeal shockwave lithotripsy has been demonstrated in previous studies [12]. These techniques have also been demonstrated to have no significant adverse effects in the long term [13]. However, there is a paucity of studies comparing the results obtained using these two pieces of equipment in the management of bladder stones. The endoscopic view of a fragmented bladder stone during lithotripsy is presented in Figure 2.

Materials and Methods
This is a retrospective study carried out from January 2013 to December 2019 at the Centre medico-chirugicale d'urologie in Douala, Cameroon. We included all patients with bladder stones who were diagnosed and managed at our center via either lithoclast or laser cystolithotripsy using a 22F Storz cystoscope and excluded patients whose files were missing some important information. We col-

Results
We recruited a total of 32 patients into this study.  There was a significant difference in the rate of use of the dormie basket between

Discussion
This study aimed to evaluate the efficacy and safety of endoscopic lithotripsy with the lithoclast (EMS, Switzerland) and laser Holmium YAG in the management of bladder calculi. The mean age of our study participants was 41.28 ± 13.99 years, which is higher than the mean age of 13 years reported by Esposito et al. in 2021 [15] but lower than the 54.70 ± 9.80 years reported by Gong et al. in the same year [14]. This difference in age is mainly because Esposito et al. carried out their study in children and Gong et al. carried out theirs in older adults who were predisposed to bladder outlet obstruction issues such as prostatic hypertrophy while we studied young adults. There were 24 (75%) men and 8 (25%) women in our study, which is in line with a report stating that the incidence of stones in men is more than twice that in women [16]. A 15:1 male-to-female ratio was also reported by Karami et al. in 2016 [17]. In our study, macroscopic hematuria (28.13%) and acute urinary retention (12.5%) were among the main clinical presentations. This is in line with the report presented by Toricelli et al. in 2017 [18], as they reported macroscopic hematuria and acute urinary retention as the two main clinical findings in their 65-year-old patient. Other clinical presentations we enlisted, including lower urinary tract symptoms (25%) and bladder irritative symptoms (9.38%), which were also re-ported by Chong et al. in 2021 [14], while pain was reported by Hammad et al. in 2006 [19]. As concerns the etiologies of the bladder stones, we reported no obvious etiology in 43.75% of cases, BPH in 34.38% of cases, VVF sutures in 6.25% of cases, calcified double-J stents in 9.38% of cases, prolapsed IUCDs in 3.13% of cases, and a neurogenic bladder in 3.13% of cases. As can be observed, all our obvious etiologies classify as bladder outlet obstruction, which is in line with the findings of the study by Douenias et al. who reported bladder outlet obstruction as the main cause of bladder stones [20]. As stated earlier, the bladder stones were managed either via lithoclast lithotripsy or laser holmium lithotripsy. The surgery duration was significantly longer in the lithoclast lithotripsy group than in the laser holmium lithotripsy group, which is in line with the results of the study carried out by Jeon et al. in 2005 [11]. However, unlike Jeon et al., we found no significant difference in the duration of hospitalization between the two groups. This is probably because unlike Jeon et al. who recruited a similar number of participants in both groups, one of the groups in our study is made of 23 participants while the other is made of just 9 participants. Sajid et al.
also reported a significantly shorter surgery duration with laser holmium lithotripsy than with lithoclast lithotripsy in 2021 [21]. All the 9 patients who underwent laser holmium lithotripsy did so under locoregional anesthesia, which is in line with the findings of Cicione et al. in 2018 [22]. As stated earlier, the only major postoperative complication reported among our study participants was fever, and no case of fever was reported in the laser holmium group. This is in line with the findings of Tipu et al. in 2007, who concluded that laser holmium lithotripsy was a superior technique to pneumatic lithoclast lithotripsy in terms of stone clearance and complications [23]. The age of the patients in the lithoclast lithotripsy group was significantly higher than that in the laser holmium lithotripsy group, which is also in line with the findings of Tipu et al. The mean stone size of the lithoclast lithotripsy group was significantly higher than that of the laser holmium lithotripsy group, which is contrary to the findings of previous studies [23] [24]. In this study, the stone clearance rate was 100% for both procedures, which is contrary to the findings of previous studies which report a higher stone clearance rate for laser holmium lithotripsy than for lithoclast lithotripsy [23] [24]. This is probably due to the fact that we recruited fewer participants and went further to use a dormia basket to extract stone fragments in certain cases to ensure a 100% stone clearance rate.

Conclusion
Both lithoclast lithotripsy and laser holmium lithotripsy are efficient in the management of bladder stones. However, laser holmium lithotripsy offers the additional advantage of a shorter surgery duration and significantly fewer postoperative complications.